GERN Geron Corporation
Healthcare$1.28+1.59%ClosedMarket Cap: $821.1M
As of 2026-05-25
Valuation
P/E (TTM)
—
PEG
—
P/B
3.74
P/S
4.19
EV/EBITDA
-24.63
DCF Value
$-6.99
FCF Yield
-15.4%
Div Yield
0.0%
Margins & Returns
Gross Margin
86.6%
Operating Margin
-19.1%
Net Margin
-35.5%
ROE
-28.9%
ROA
-13.0%
ROIC
-7.8%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $51.8M | 96.7% | $-236.0K | $-3.6M | $— | — |
| Q4 null | $48.0M | 97.3% | $-10.8M | $-31.1M | $— | — |
| FY null | $183.9M | 97.4% | $-53.8M | $-85.8M | $— | — |
| Q3 null | $47.2M | 53.2% | $-13.9M | $-18.4M | $— | — |
| Q2 null | $49.0M | 97.6% | $-12.5M | $-16.4M | $— | — |
| Q1 null | $39.6M | 97.0% | $-16.7M | $-19.8M | $— | — |
| Q4 null | $47.5M | 98.4% | $-20.1M | $-25.4M | $— | — |
| FY null | $77.0M | 98.4% | $-173.7M | $-174.6M | $— | — |
| Q3 null | $28.3M | 98.4% | $-28.2M | $-26.4M | $— | — |
| Q2 null | $882.0K | 98.1% | $-69.3M | $-67.4M | $— | — |
| Q1 null | $304.0K | 100.0% | $-56.1M | $-55.4M | $— | — |
| Q4 2023 | $23.0K | 100.0% | $-54.3M | $-52.0M | $-0.09 | — |